Hyperplasia of pulmonary artery SMCs (PASMCs) is a pathological hallmark of pulmonary arterial hypertension (PAH). In this issue of the JCI, McMurtry et al. report that adenovirus-mediated overexpression of survivin — a multipotent inhibitor of apoptosis — induces PAH in rats, whereas inhalation of an adenovirus vector encoding a mutant survivin gene with dominant-negative properties reverses established monocrotaline-induced PAH. These findings raise important issues regarding the role of survivin in the pathogenesis of PAH, its value as a prognostic indicator, and its use as a target for new therapeutic strategies.
Serge Adnot
Title and authors | Publication | Year |
---|---|---|
Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation
Zhang L, Wang Y, Wu G, Rao L, Wei Y, Yue H, Yuan T, Yang P, Xiong F, Zhang S, Zhou Q, Chen Z, Li J, Mo B, Zhang H, Xiong W, Wang C |
Cell Proliferation | 2020 |
Role for Telomerase in Pulmonary Hypertension
N Mouraret, A Houssaini, S Abid, R Quarck, E Marcos, A Parpaleix, G Gary-Bobo, JL Dubois-Rande, G Derumeaux, J Boczkowski, M Delcroix, MA Blasco, L Lipskaia, V Amsellem, S Adnot |
Circulation | 2014 |
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
A Boueiz, PM Hassoun |
Annals of thoracic medicine | 2014 |
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
A Houssaini, S Abid, N Mouraret, F Wan, D Rideau, M Saker, E Marcos, CM Tissot, JL Dubois-Randé, V Amsellem, S Adnot |
American journal of respiratory cell and molecular biology | 2013 |
Pulmonary Arterial Hypertension in Connective Tissue Diseases
SC Mathai, PM Hassoun |
Heart Failure Clinics | 2012 |
Pulmonary arterial hypertension associated with systemic sclerosis
Mathai SC, Hassoun PM |
Expert Review of Respiratory Medicine | 2011 |
Effects of HIV Protease Inhibitors on Progression of Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension in Rats
G Gary-Bobo, A Houssaini, V Amsellem, D Rideau, P Pacaud, A Perrin, J Brégeon, E Marcos, JL Dubois-Randé, O Sitbon, L Savale, S Adnot |
Circulation | 2010 |
Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease
J Tian, S Fratz, Y Hou, Q Lu, A Görlach, J Hess, C Schreiber, SA Datar, P Oishi, J Nechtman, R Podolsky, JX She, JR Fineman, SM Black |
Physiological genomics | 2010 |
Lung Involvement in Systemic Sclerosis
PM Hassoun |
Presse medicale (Paris, France : 1983) | 2010 |
Cellular and molecular basis of pulmonary arterial hypertension
NW Morrell, S Adnot, SL Archer, J Dupuis, PL Jones, MR MacLean, IF McMurtry, KR Stenmark, PA Thistlethwaite, N Weissmann, JX Yuan, EK Weir |
Journal of the American College of Cardiology | 2009 |
Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype
BN Davis, AC Hilyard, PH Nguyen, G Lagna, A Hata |
The Journal of biological chemistry | 2009 |
Therapies for scleroderma-related pulmonary arterial hypertension
PM Hassoun |
Expert Review of Respiratory Medicine | 2009 |
A Dosing/Cross-Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension
M Gomberg-Maitland, ML Maitland, RJ Barst, L Sugeng, S Coslet, TJ Perrino, L Bond, ME Lacouture, SL Archer, MJ Ratain |
Clinical Pharmacology & Therapeutics | 2009 |
Therapy for Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
Mathai SC, Hassoun PM |
Current Opinion in Rheumatology | 2009 |